학술논문

Glucose Measurement and Control in Patients with Type 1 or Type 2 Diabetes.
Document Type
Article
Source
Experimental & Clinical Endocrinology & Diabetes. 2022 Supplement 1, Vol. 130, pS19-S38. 20p.
Subject
*TYPE 1 diabetes
*GLUCOSE
*HYPERGLYCEMIA
*OXYGEN in the blood
*BLOOD sugar
*TYPE 2 diabetes
*PHYSICIANS
Language
ISSN
0947-7349
Abstract
B For users of CGM systems, the number of blood glucose measurements can be reduced, but never completely dispensed with. b Quality control (Internal and external/interlaboratory comparisons) Quality control for personal glucose measurement systems can be performed by the patient with a system-specific control solution; these are offered by manufacturers for their products. SMBG systems still have the largest market share of glucose monitoring systems in the field of diabetes technology - in part, due to the lower costs compared to rtCGM/iscCGM systems. Available systems There are various systems on the market; they can be differentiated according to measuring principles and laboratory systems, POCT (Point of Care) systems and small desktop devices that can also be used by patients. If company X comes onto the market with a new pump linked to a CGM system and the patient still has a similar CGM system and performs ICT, experience shows that the change is difficult because the MDK initially wants the patient to try out pump X alone with the "old" CGM system. Patient symptoms are more important than a measurement value, in case of discrepancies repeat measurement.SMBG systems Due to further technical development and damage to the device caused by use, SMBG systems should be replaced every few years. If several/different SMBG systems are used at the same time, note the differences in operation. [Extracted from the article]